Zadnji put ažurirano :
29/10/2024
antibiotik   Temocilline  
injekcija
Stabilizacija rješenja Stabilnost mješavine Stabilizacijski faktor Kompatibilnosti način davanja lijeka Bibliografija pdf
   Kemijska struktura  

Nekomercijalni   Nekomercijalni     

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Negaban Belgija, Francuska, Luksemburg, Velika Britanija
Bibliografija   injekcija   Bibliografija : Temocilline  
Vrsta Publikacija
2231 Časopis de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2275 Časopis Craig Dyar S, Notari RE.
Hydrolysis kinetics and stability predictions for a mixture of R and S temocillin isomers.
Int J Pharm 1998 ; 173: 221-232.
2296 Laboratorija Témocilline (Negaban®) - Résumé des caractéristiques du produit
Eumedica 2017
3154 Časopis Carryn S, Couwenbergh N, Tulkens PM
Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients.
J Antimicrob Chemother 2010 ; 65, 9: 2045-2046.
3255 Časopis Rolin C, Hecq J.D, Tulkens P, Vanbeckbergen D, Jamart J, LGalanti L.
Long-term stability of temocillin in dextrose 5% and in sodium chloride 0.9% polyolefin bags at 5±3°C after freeze-thaw treatment
Ann Pharm Fr 2011 ; 69, 6 : 296-301.
3385 Časopis Raverdi V, Ampe E, Hecq JD, Tulkens PM.
Stability and compatibility of vancomycin for administration by continuous infusion.
J Antimicrob Chemother 2013 ; 68: 1179-1182.
3520 Laboratorija Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3529 Laboratorija Ciprofloxacin – Summary of Product Characteristics
Hospira 2013
3549 Laboratorija Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3643 Laboratorija Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3674 Laboratorija Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
4470 Časopis Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P.
Continuous versus intermittent infusion of temocillin in intensive care unit patient.
Critical care 2005 ; 9(Suppl 1) P37
4634 Časopis Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A.
Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy.
Antibiotics 2022 ;11,4: 458

  Mentions Légales